Autoantibodies to JA2ic and to Phogrin increase the prediction for insulin requirement in patients with Type 2 Diabetes

Autoantibodies to JA2ic and to Phogrin increase the prediction for insulin requirement in patients with Type 2 Diabetes

Bibliographic Details
Main Authors:	Bosi, E, Locatelli, M, Cull, C, Scirpoli, M, Bobifacio, E, Stratton, I, Holman, R, Bottazzo, G, Grp, U
Format:	Journal article
Published:	2001

Similar Items

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
by: Bottazzo, G, et al.
Published: (2005)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (vol 48, pg 703, 2005)
by: Bottazzo, G, et al.
Published: (2005)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
by: Davis, T, et al.
Published: (2005)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
by: Turner, R, et al.
Published: (1997)

Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9)
by: Bottazzo, G, et al.
Published: (2005)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
by: Mehta, Z, et al.
Published: (1999)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
by: Turner, R, et al.
Published: (1997)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (2000)

GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement
by: Desai, M, et al.
Published: (2004)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
by: Matthews, DR, et al.
Published: (1998)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

A family study of the association between insulin dependent diabetes mellitus, autoantibodies and the HLA system.
by: Winearls, B, et al.
Published: (1984)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
by: Matthews, DR, et al.
Published: (1998)

Investigation of Monogenic Diabetes Genes in Thai Children with Autoantibody Negative Diabetes Requiring Insulin
by: Teerawattanapong N, et al.
Published: (2024-02-01)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
by: Manley, SE, et al.
Published: (2000)

MULTICENTER TRIAL OF MIGLITOL IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES
by: Stratton, I, et al.
Published: (1992)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
by: Eeley, E, et al.
Published: (1996)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
by: Wright, A, et al.
Published: (2006)

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.
by: Davis, T, et al.
Published: (2003)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
by: Widjaja, A, et al.
Published: (1996)

Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
by: Cull, C, et al.
Published: (1997)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
by: Widjaja, A, et al.
Published: (1997)

Autoantibodies to islet amyloid polypeptide in diabetes.
by: Clark, A, et al.
Published: (1991)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (1999)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
by: Wright, A, et al.
Published: (2002)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
by: Eeley, E, et al.
Published: (1996)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
by: Adler, A, et al.
Published: (2005)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
by: Horton, V, et al.
Published: (1999)

AUTOANTIGEN PRESENTATION BY TARGET-CELLS - ITS POSSIBLE ROLE IN DETERMINING AUTOANTIBODY SPECIFICITY
by: Todd, I, et al.
Published: (1986)

Glycaemia and vascular effects of type 2 diabetes - Reply
by: Stratton, I, et al.
Published: (2001)

DIETARY EVALUATION IN TYPE-II DIABETIC SUBJECTS RANDOMLY ALLOCATED TO INSULIN, SULFONYLUREA OR DIET THERAPY
by: Eeley, E, et al.
Published: (1992)

A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
by: Phillips, M, et al.
Published: (1979)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
by: Stratton, I, et al.
Published: (2006)

Susceptibility effects of variation at the IDDM2 (Insulin-gene) locus in latent autoimmune diabetes in adults (LADA).
by: Desai, M, et al.
Published: (2003)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
by: Cull, C, et al.
Published: (1993)

Intermediate acting insulin for type 2 diabetes.
by: Turner, R, et al.
Published: (1985)

Insulin Regimens in Type 2 Diabetes REPLY
by: Holman, R, et al.
Published: (2010)